• Phase III of LHRH analog administration during chemotherapy to reduce ovarian failure following chemotherapy in early stage, hormone-receptor breast cancer Prevention Of Early Menopause Study - POEMS

  • Study Chairs
    IBCSG: Dr. Kelly-Anne Phillips - Melbourne, Australia
    SWOG: Dr. Halle C. F. Moore - Cleveland, USA

    Statistician
    Prof. RIchard Gelber

    Trial Coordinators
    Ann Lange, Emma Macdonald

    Frontier Science (Scotland) Ltd.
    Grampian View
    Kincraig, Kingussie
    PH21 1NA
    Phone: +44 1540 651 000
    Fax: +44 1540 651 007
    Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

    Date of Activation
    March 15, 2006

    Date of Closure
    Juni 1, 2011

    Targeted Accrual
    416 patients

ETOP IBCSG Partners Foundation
Effingerstrasse 33
3008 Bern, Switzerland

Contact
Phone: +41 31 511 94 00
E-mail: contact@etop.ibcsg.org

Member Login